GEOVAX LABS, INC. Conversion of Stock, Shares Issued
GEOVAX LABS, INC. (GOVX) reported Conversion of Stock, Shares Issued of 716.79 thousand shares for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2022-03-09
- GEOVAX LABS, INC. conversion of stock, shares issued for the quarter ending 2020-12-31 was 0.00 shares.
- GEOVAX LABS, INC. conversion of stock, shares issued for the quarter ending 2018-12-31 was -66.67M shares, a 933.33% decline year-over-year.
- GEOVAX LABS, INC. conversion of stock, shares issued for the quarter ending 2018-09-30 was 13.67M shares, a 70.83% increase year-over-year.
- GEOVAX LABS, INC. conversion of stock, shares issued for the quarter ending 2018-06-30 was 23.00M shares.
- GEOVAX LABS, INC. conversion of stock, shares issued for fiscal 2020 was 716.79K shares, a 141.84% increase from fiscal 2019.
- GEOVAX LABS, INC. conversion of stock, shares issued for fiscal 2019 was 296.39K shares, a 311889.47% increase from fiscal 2018.
- GEOVAX LABS, INC. conversion of stock, shares issued for fiscal 2018 was 95.00 shares, a 100.00% decline from fiscal 2017.
- GEOVAX LABS, INC. conversion of stock, shares issued for fiscal 2017 was 19.86M shares, a 1318.71% increase from fiscal 2016.
| Period end | Conversion of Stock, Shares Issued 3 month | Conversion of Stock, Shares Issued 6 month | Conversion of Stock, Shares Issued 9 month | Conversion of Stock, Shares Issued 12 month |
|---|---|---|---|---|
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | 716.79K shares 10-K · filed 2022-03-09 | ||
| 2020-09-30 | 716.79K shares 10-Q · filed 2021-11-12 | |||
| 2019-12-31 | 296.39K shares 10-K · filed 2020-03-24 | |||
| 2018-12-31 | -66.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | -53.00M shares derived: sum of 2 quarters · filed 2020-03-24 | -30.00M shares derived: sum of 3 quarters · filed 2020-03-24 | 95.00 shares 10-K · filed 2020-03-24 |
| 2018-09-30 | 13.67M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 36.67M shares derived: sum of 2 quarters · filed 2018-11-08 | 66.67M shares 10-Q · filed 2018-11-08 | 74.67M shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 23.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 53.00M shares 10-Q · filed 2018-08-07 | 61.00M shares derived: sum of 3 quarters · filed 2018-08-07 | 69.00M shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-03-31 | 30.00M shares 10-Q · filed 2018-05-03 | 38.00M shares derived: sum of 2 quarters · filed 2018-05-03 | 46.00M shares derived: sum of 3 quarters · filed 2018-11-08 | |
| 2017-12-31 | 8.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | 16.00M shares derived: sum of 2 quarters · filed 2018-11-08 | 19.86M shares 10-K · filed 2018-03-23 | |
| 2017-09-30 | 8.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 11.86M shares 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | 3.86M shares 10-Q · filed 2018-08-07 | |||
| 2016-12-31 | 1.40M shares 10-K · filed 2018-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |